Terms: = Pancreatic cancer AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Treatment
17 results:
1. Comparison Between Plastic and Metallic Biliary Stent Placement for Preoperative Patients with pancreatic Head cancer: A Systematic Review and Meta-Analysis.
Endo Y; Tanaka M; Kitago M; Yagi H; Abe Y; Hasegawa Y; Hori S; Nakano Y; Iwasaki E; Kitagawa Y
Ann Surg Oncol; 2024 Feb; 31(2):1319-1327. PubMed ID: 37952017
[TBL] [Abstract] [Full Text] [Related]
2. Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.
Gordon S; Chan DLH; Bernard EJ; Eslick ME; Willowson KP; Roach PJ; Engel AF; Maher R; Clarke SJ; Agarwal V; Yasmin L; De Silva M; Mascall S; Conner A; Nevell D; Pavlakis N; Bailey DL
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7717-7728. PubMed ID: 37004598
[TBL] [Abstract] [Full Text] [Related]
3. Antiproliferative potential of
Sayed AM; El-Hawary SS; Abdelmohsen UR; Ghareeb MA
Food Funct; 2022 Nov; 13(22):11733-11743. PubMed ID: 36281695
[No Abstract] [Full Text] [Related]
4. Post-Acute Care Outcomes and Functional Status Changes of Adults with New cancer Discharged to Skilled Nursing Facilities.
Singh S; Molina E; Meyer E; Min SJ; Fischer S
J Am Med Dir Assoc; 2022 Nov; 23(11):1854-1860. PubMed ID: 35337793
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series.
Goncalves I; Burbury K; Michael M; Iravani A; Ravi Kumar AS; Akhurst T; Tiong IS; Blombery P; Hofman MS; Westerman D; Hicks RJ; Kong G
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1902-1910. PubMed ID: 31187162
[TBL] [Abstract] [Full Text] [Related]
6. Salvage peptide receptor radionuclide therapy with [
van der Zwan WA; Brabander T; Kam BLR; Teunissen JJM; Feelders RA; Hofland J; Krenning EP; de Herder WW
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):704-717. PubMed ID: 30267116
[TBL] [Abstract] [Full Text] [Related]
7. Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with
Bergsma H; van Lom K; Raaijmakers MHGP; Konijnenberg M; Kam BLBLR; Teunissen JJM; de Herder WW; Krenning EP; Kwekkeboom DJ
J Nucl Med; 2018 Mar; 59(3):452-458. PubMed ID: 28775205
[TBL] [Abstract] [Full Text] [Related]
8. Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancer.
Yarchoan M; Myzak MC; Johnson BA; De Jesus-Acosta A; Le DT; Jaffee EM; Azad NS; Donehower RC; Zheng L; Oberstein PE; Fine RL; Laheru DA; Goggins M
Oncotarget; 2017 Jul; 8(27):44073-44081. PubMed ID: 28454122
[TBL] [Abstract] [Full Text] [Related]
9. Myelotoxicity of Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Decade of Experience.
Kesavan M; Turner JH
Cancer Biother Radiopharm; 2016 Aug; 31(6):189-98. PubMed ID: 27419665
[TBL] [Abstract] [Full Text] [Related]
10. Laparoscopic versus open distal pancreatectomy for pancreatic cancer.
Riviere D; Gurusamy KS; Kooby DA; Vollmer CM; Besselink MG; Davidson BR; van Laarhoven CJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011391. PubMed ID: 27043078
[TBL] [Abstract] [Full Text] [Related]
11. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.
Hüttner FJ; Fitzmaurice C; Schwarzer G; Seiler CM; Antes G; Büchler MW; Diener MK
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD006053. PubMed ID: 26905229
[TBL] [Abstract] [Full Text] [Related]
12. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.
Diener MK; Fitzmaurice C; Schwarzer G; Seiler CM; Hüttner FJ; Antes G; Knaebel HP; Büchler MW
Cochrane Database Syst Rev; 2014 Nov; 11(11):CD006053. PubMed ID: 25387229
[TBL] [Abstract] [Full Text] [Related]
13. Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q- syndrome.
Burwick N; Shimamura A; Liu JM
Semin Hematol; 2011 Apr; 48(2):136-43. PubMed ID: 21435510
[TBL] [Abstract] [Full Text] [Related]
14. Fixed-dose-rate gemcitabine: a viable first-line treatment option for advanced pancreatic and biliary tract cancer.
Milella M; Gelibter AJ; Pino MS; Bossone G; Marolla P; Sperduti I; Cognetti F
Oncologist; 2010; 15(2):e1-4. PubMed ID: 20189980
[TBL] [Abstract] [Full Text] [Related]
15. Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.
Drugs R D; 2003; 4(6):352-8. PubMed ID: 14584964
[TBL] [Abstract] [Full Text] [Related]
16. Granulocytic sarcoma: report of three cases.
Mwanda WO; Rajab JA
East Afr Med J; 1999 Oct; 76(10):594-6. PubMed ID: 10734514
[TBL] [Abstract] [Full Text] [Related]
17. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
Sokolic RA; Ferguson W; Mark HF
Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
[TBL] [Abstract] [Full Text] [Related]
